PA
LLY icon

Paragon Advisors’s Eli Lilly LLY Stock Holding History

Paragon Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.84M Sell
4,037
-929
-19% -$949K 1.02% 25
2026
Q1 		$4.57M Sell
4,966
-76
-2% -$77K 1.23% 22
2025
Q4 		$5.42M Buy
5,042
+335
+7% +$320K 1.47% 18
2025
Q3 		$3.59M Sell
4,707
-1,740
-27% -$1.29M 0.93% 32
2025
Q2 		$5.03M Buy
6,447
+78
+1% +$60.6K 1.31% 18
2025
Q1 		$5.26M Sell
6,369
-18
-0.3% -$15K 1.99% 12
2024
Q4 		$4.93M Sell
6,387
-136
-2% -$113K 1.69% 18
2024
Q3 		$5.78M Buy
6,523
+28
+0.4% +$25.2K 1.88% 11
2024
Q2 		$5.88M Buy
6,495
+2,933
+82% +$2.35M 2.14% 11
2024
Q1 		$2.77M Buy
3,562
+1,332
+60% +$948K 1.12% 27
2023
Q4 		$1.3M Buy
2,230
+511
+30% +$298K 0.55% 54
2023
Q3 		$923K Buy
1,719
+133
+8% +$68.5K 0.38% 65
2023
Q2 		$743K Sell
1,586
-2,410
-60% -$1.01M 0.24% 83
2023
Q1 		$1.37M Buy
3,996
+1,413
+55% +$477K 0.46% 54
2022
Q4 		$944K Buy
+2,583
New +$916K 0.42% 55

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Paragon Advisors's LLY Position: Q2 2026 in Review

Paragon Advisors reduced its Eli Lilly (LLY) stake by 19% in Q2 2026, selling an estimated $949K and leaving 4,037 shares worth $4.84M. The position accounts for 1.02% of the portfolio, ranked #25.

Paragon Advisors first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.88M in Q2 2024. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Paragon Advisors held 4,037 shares of Eli Lilly worth $4.84M as of Q2 2026.
  • Paragon Advisors sold 929 Eli Lilly shares in Q2 2026, an estimated $949K.
  • Eli Lilly made up 1.02% of Paragon Advisors's portfolio in Q2 2026, its #25 holding.
  • Paragon Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • Paragon Advisors's Eli Lilly position peaked at $5.88M in Q2 2024.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Paragon Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.